Literature DB >> 26710845

Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy.

J Lakota1, K Gocarova2, S Spanik2.   

Abstract

This is a clinical observation of a patient treated for metastatic head and neck cancer with mesenchymal stem cells mediated prodrug gene therapy. The cells were applied intravenously. We did not observe any therapeutic effect. However, a temporal bicytopenia was observed.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26710845

Source DB:  PubMed          Journal:  Exp Oncol        ISSN： 1812-9269


  2 in total

1.  Fate of human mesenchymal stem cells (MSCs) in humans and rodents-Is the current paradigm obtained on rodents applicable to humans?

Authors:  Jan Lakota
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

Review 2.  Enhancement of the Therapeutic Capacity of Mesenchymal Stem Cells by Genetic Modification: A Systematic Review.

Authors:  Jeanne Adiwinata Pawitan; Thuy Anh Bui; Wildan Mubarok; Radiana Dhewayani Antarianto; Retno Wahyu Nurhayati; Ismail Hadisoebroto Dilogo; Delvac Oceandy
Journal:  Front Cell Dev Biol       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.